Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
570.00    -16.00 (-2.73%)
Bid:
570.00
Ask:
572.00
Spread: 2.00 (0.351%)
Market Cap: £1.05b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Capital Markets Event

22 Apr 2026 07:00

RNS Number : 3844B
Volex PLC
22 April 2026
 

 

 

22 April 2026

Volex plc

("Volex" or the "Group")

Capital Markets Event and New Medium Term Growth Ambitions

 

Volex plc (AIM: VLX), a critical manufacturing partner to category leaders delivering complex power and data connectivity systems, is hosting a Capital Markets Event ("CME") for institutional investors and analysts at 14.00 BST today at the offices of Peel Hunt LLP, 100 Liverpool Street, London, EC2M 2AT.

 

The event will be hosted by Dave Webster, Chair, Nat Rothschild, Chief Executive Officer, Jon Boaden, Chief Financial Officer and John Molloy, Group Chief Operating Officer, alongside other members of Volex's senior management team.

 

At the CME, management will present a comprehensive overview of Volex's strategy, operating model and new medium-term growth ambitions, demonstrating how the Group has been transformed into a complexity-led manufacturer of integrated systems, positioned for sustained, high-quality, profitable growth.

 

Presentations on the day will outline:

 

·

The long-term structural trends shaping Volex's chosen end-markets, including electrification, data centres, medical technology innovation, advanced industrial systems and off-highway equipment.

·

Volex's strategy of partnering and growing with category leaders in each of its core markets, many of whom define their industries and operate at the forefront of technological change.

·

Volex's differentiated operating model, which combines a single global operating framework with local decision-making close to customers.

 

Medium-term growth ambitions

 

Having achieved its five-year plan to FY271 a year early, at the CME, Volex will outline the following new medium-term growth ambitions:

 

·

$2bn of revenue, including:

Organic revenue growth of $500m

c. $300m of revenues added from targeted M&A

·

12% EBIT margins

·

20%+ return on capital employed

 

Conditions in Volex's markets and the FY2026 guidance provided at the Group's Year End Trading Update on 25 March remain unchanged. No new information on current year trading will be shared at the event.

 

Presentations will start at 14.00 BST and will be followed by a question-and-answer session. 

 

Institutional investors and sell-side equity analysts who are interested in attending in person should contact Sodali & Co at: Volex@sodali.com

 

For those unable to attend in-person, a live webcast of the presentation will be available via: https://brrmedia.news/VLX_CME_26

 

All presentation materials and a recording of the event will be available on Volex's investor relations website shortly after the event.

 

1 All forecasts implied by or relating to the five-year plan to FY27 as originally announced on 23 June 2022 have been withdrawn and replaced in its entirety by the new medium-term targets.

 

-ENDS-

For further information please contact:

 

Volex plc

+44 (0) 1256 442570

Nat Rothschild, Chief Executive Officer

investor.relations@volex.com

Jon Boaden, Chief Financial Officer

Peel Hunt LLP - Nominated Adviser & Joint Broker

+44 (0) 20 7418 8900

Ed Allsopp

Dom Convey

Tom Graham

Jefferies - Joint Broker

+44 (0) 20 7029 8000

Philip Noblet

Sam Barnett

Harry Le May

Sodali & Co - Media Enquiries

+44 (0) 20 7250 1446

James White

Nicholas Johnson

 

About Volex plc

Volex plc (AIM:VLX) is a driving force in integrated manufacturing for mission-critical applications and a global leader in power and data connectivity solutions. Our diverse operations support international blue-chip customers in five key end-markets: Electric Vehicles, Consumer Electricals, Medical, Complex Industrial Technology and Off-Highway. Headquartered in the UK, we orchestrate operations across 23 advanced manufacturing facilities, uniting 13,000 dynamic individuals from 25 different nations. Our extraordinary products find their way to market through our localised sales teams and authorised distributor partners, supporting Original Equipment Manufacturers and Electronic Manufacturing Services companies across the globe. In a world that grows more digitally complex by the day, customers trust us to deliver power and connectivity that drives everything from household essentials to life-saving medical equipment. Learn more at www.volex.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCIBMPTMTMTBJF
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.